Nitric oxide and tubulointerstitial nephritides

Seminars in Nephrology

Volumn 24, Issue 4, 2004, Pages 345-353

  Mattana, Joseph ^a   Adamidis, Ananea ^b   Singhal, Pravin C ^b  

^a LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE;

BLOOD VESSEL; BODY GROWTH; GROWTH; HUMAN; INTERSTITIAL NEPHRITIS; ISCHEMIA; KIDNEY; PRIORITY JOURNAL; PROTEINURIA; REVIEW; SEPSIS;

EID: 3142526414     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2004.04.006     Document Type: Article

References (54)

1. Gow A.J., Stamler J.S. Reactions between nitric oxide and haemoglobin under physiological conditions. Nature. 391:1998;169-173
2. Ronson R.S., Nakamura M., Vinten-Johansen J. The cardiovascular effects and implications of peroxynitrite. Cardiovasc Res. 44:1999;47-59
3. Thomson S.C., Bachmann S., Bostanjoglo M., et al. Temporal adjustment of the juxtaglomerular apparatus during sustained inhibition of proximal reabsorption. J Clin Invest. 104:1999;1149-1158
4. Ichihara A., Inscho E.W., Imig J.D., et al. Neuronal nitric oxide synthase modulates rat renal microvascular function. Am J Physiol. 274:1998;F516-F524
5. MacMicking J., Xie Q.-W., Nathan C. Nitric oxide and macrophage function. Annu Rev Immunol. 15:1997;323-350
6. Baylis C., Mitruka B., Deng A. Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J Clin Invest. 90:1992;278-281
7. Baylis C., Harton P., Engels K. Endothelium-derived relaxing factor controls renal hemodynamics in the normal rat kidney. J Am Soc Nephrol. 1:1990;875-881
8. Ferrario R., Takahashi K., Fogo A., et al. Consequences of acute nitric oxide synthesis inhibition in experimental glomerulonephritis. J Am Soc Nephrol. 4:1994;1847-1854
9. Nicola L.D., Blantz R.C., Gabbai F.B. Nitric oxide and angiotensin II Glomerular and tubular interactions in the rat. J Clin Invest. 89:1988;1248-1256
10. Baylis C., Qiu C. Importance of nitric oxide in the control of renal hemodynamics. Kidney Int. 49:1996;1727-1731
11. Zatz R., De Nucci G. Effects of acute nitric oxide inhibition on rat glomerular microcirculation. Am J Physiol. 261:1991;F360-F363
12. Blantz R.C., Konnen K.S., Tucker B.J. Angiotensin II effects upon glomerular microcirculation and ultrafiltration coefficient of the rat. J Clin Invest. 57:1976;419-434
13. Stoos B.A., Garcia N.H., Garvin J.L. Nitric oxide inhibits sodium reabsorption in the isolated perfused cortical collecting duct. J Am Soc Nephrol. 6:1995;89-94
14. Kang D.G., Kim J.W., Lee J. Effects of nitric oxide synthesis inhibition on the NaK-ATPase activity in the kidney. Pharmacol Res. 41:2000;121-125
15. Garcia N.H., Pomposiello S.I., Garvin J.L. Nitric oxide inhibits ADH-stimulated osmotic water permeability in cortical collecting ducts. Am J Physiol. 270:1996;F206-F210
16. Bech J.N., Nielsen C.B., Ivarsen P., et al. Dietary sodium affects systemic and renal hemo-dynamic response to NO inhibition in healthy humans. Am J Physiol. 274:1998;F914-F923
17. Stout R., Suttles J., Xu J., et al. Impaired T cell-mediated macrophage activation in CD40 ligand-deficient mice. J Immunol. 156:1996;8-11
18. Xie Q.-W., Cho H., Calaycay J., et al. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science. 256:1992;225-228
19. Xie Q.-W., Whisnant R., Nathan C. Promoter of the mouse gene encoding calcium independent nitric oxide synthase confers inducibility by interferon-gamma and bacterial lipopolysaccharide. J Exp Med. 177:1993;1779-1784
20. Xie Q.-W., Kashiwabara Y., Nathan C. Role of transcription factor NFkB/Rel in the induction of nitric oxide synthase. J Biol Chem. 269:1994;4705-4708
21. Koblish H., Hunter C., Wysocka M., et al. Immune suppression by recombinant interleukin 12 involves interferon-gamma induction of nitric oxide synthase 2 (iNOS) activity Inhibitors of no generation reveal the extent of rIL-12 vaccine adjuvant effect. J Exp Med. 188:1998;1603-1610
22. Cole B.C., Griffiths M.M., Sullivan G.J., et al. Role of non-RT1 genes in the response of rat lymphocytes to mycoplasma arthritidis T cell mitogen, concanavalin A And phytohemagglutinin. J Immunol. 136:1986;2364-2369
23. Newlin C.M., Gasser D.L. Genetic control of the in vitro responses of rat peripheral blood lymphocytes to PHA and Con A. J Immunol. 110:1973;622-628
24. Fu Y., Blankenhorn E. Nitric oxide-induced anti-mitogenic effects in high and low responder rat strains. J Immunol. 148:1992;2217-2222
25. Wei X.-Q., Charles I.G., Smith A., et al. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature. 375:1995;408-411
26. Kelly C.J., Gold D.P. Nitric oxide in interstitial nephritis and other autoimmune diseases. Semin Nephrol. 19:1999;288-295
27. Gabbai F.B., Boggiano C., Peter T., et al. Inhibition of inducible nitric oxide synthase intensifies injury and functional deterioration in autoimmune interstitial nephritis. J Immunol. 159:1997;6266-6275
28. Gabbai F.B., Hammond T.C., Thomson S.C., et al. Effect of acute iNOS inhibition on glomerular function in tubulointerstitial nephritis. Kidney Int. 61:2002;851-854
29. Johnson R.J., Gordon K.L., Suga S., et al. Renal injury and salt-sensitive hypertension after exposure to catecholamines. Hypertension. 34:2000;151-159
30. Johnson R.J., Schreiner G. Hypothesis Is essential hypertension an acquired tubulointerstitial renal disease? Kidney Int. 52:1997;1169-1179
31. Lombardi D., Gordon K.I., Polinsky P., et al. Salt-sensitive hypertension develops after short-term exposure to angiotensin II. Hypertension. 33:1999;1013-1019
32. Baylis C., Mitruka B., Deng A. Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J Clin Invest. 90:1992;278-281
33. Kashiwagi M., Shinozaki M., Hirakata H., et al. Locally activated renin-angiotensin system associated with TGF-beta1 as a major factor for renal injury induced by chronic inhibition of nitric oxide synthase in rats. J Am Soc Nephrol. 11:2000;616-624
34. Melaragno M.G., Fink G.D. Role of ANG II in hypertension produced by chronic inhibition of nitric oxide synthase in conscious rats. Am J Physiol. 271:1996;H806-H811
35. Spiecker M., Darius H., Kaboth K., et al. Differential regulation of endothelial cell adhesion molecule expression by nitric oxide donors and antioxidants. J Leukoc Biol. 63:1998;732-739
36. Allison A.C., Eugui E.M. Mycophenolate mofetil and its mechanism of action. Immunopharmacology. 47:2000;85-118
37. Fujihara C.K., Avancini Costa Malheiros D.M., de Lourdes Noronha II, et al. Mycophenolate mofetil reduces renal injury in the chronic nitric oxide synthase inhibition model. Hypertension. 37:2001;170-175
38. Abbate M., Remuzzi G. Proteinuria as a mediator of tubulointerstitial injury. Kidney Blood Press Res. 22:1999;37-46
39. Rangan G.K., Wang Y., Harris D.C.H. Pharmacologic modulators of nitric oxide exacerbate tubulointerstitial inflammation in proteinuric rats. J Am Soc Nephrol. 12:2001;1696-1705
40. Kang D.H., Nakagawa T., Feng L., et al. Nitric oxide modulates vascular disease in the remnant kidney model. Am J Pathol. 161:2002;239-248
41. Truong L.D., Petrusevska G., Yang G., et al. Cell apoptosis and proliferation in experimental chronic obstructive uropathy. Kidney Int. 50:1996;200-207
42. Teramoto T., Kiss A., Thorgeirsson S.S. Induction of p53 and Bax during TGF-beta-1 initiated apoptosis in rat liver epithelial cells. Biochem Biophys Res Commun. 251:1998;56-60
43. Basile D.P., Liapis H., Hammerman M.R. Expression of Bcl-2 and Bax in regenerating rat renal tubules following ischemic injury. Am J Physiol. 272:1997;F640-F647
44. Morrissey J.J., Ishidoya S., McCracken R., et al. Nitric oxide generation ameliorates the tubulointerstitial fibrosis of obstructive uropathy. J Am Soc Nephrol. 7:1996;2202-2212
45. Huang A., Palmer L.S., Hom D., et al. The role of nitric oxide in obstructive nephropathy. J Urol. 163:2000;1276-1281
46. Vodovotz Y., Geiser A.G., Chesler L., et al. Spontaneously increased production of nitric oxide and aberrant expression of the inducible nitric oxide synthase in vivo in the transforming growth factor beta 1 null mouse. J Exp Med. 183:1996;2337-2342
47. Miyajima A., Chen J., Lawrence C., et al. Antibody to transforming growth factor-beta ameliorates tubular apoptosis in unilateral ureteral obstruction. Kidney Int. 58:2000;2301-2313
48. Chatterjee P.K., Patel N.S.A., Kvale E.O., et al. Inhibition of inducible nitric oxide synthase reduces renal ischemia/reperfusion injury. Kidney Int. 61:2002;862-871
49. Wangsiripaisan A., Gengaro P.E., Nemenoff R.A., et al. Effect of nitric oxide donors on renal tubular epithelia cell-matrix adhesion. Kidney Int. 55:1999;2281-2288
50. Bank N., Aynedjian H.S., Qui J.-H., et al. Renal nitric oxide synthases in transgenic sickle cell mice. Kidney Int. 50:1996;184-189
51. Bank N., Kiroycheva M., Ahmed F., et al. Peroxynitrite formation and apoptosis in transgenic sickle cell mouse kidneys. Kidney Int. 54:1998;1520-1528
52. Bank N., Kiroycheva M., Singhal P.C., et al. Inhibition of nitric oxide synthase ameliorates cellular injury in sickle cell mouse kidneys. Kidney Int. 58:2000;82-89
53. Glynne P.A., Picot J., Evans T.J. Coexpressed nitric oxide synthase and apical beta(1) integrins influence tubule cell adhesion after cytokine-induced injury. J Am Soc Nephrol. 12:2001;2370-2383
54. Amore A., Emancipator S.N., Cirina P., et al. Nitric oxide mediates cyclosporine-induced apoptosis in cultured renal cells. Kidney Int. 57:2000;1549-1559